Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15, 722

Authors

Institutions

Publication Details

Journal
Life
Published
2026-06-18
DOI
https://doi.org/10.3390/life16061021
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15, 722

Selman Aktaş, Nizameddin Koca, Seyit Uyar, Nazif Yalçın
Life
Diabetes Treatment and Management
article

Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15, 722

Selman Aktaş, Nizameddin Koca, Seyit Uyar, Nazif Yalçın
article en

Abstract

No abstract available for this paper.
LifeVol. 16(6)
University of Health Science (KH), Bursa Technical University (TR), Sağlık Bilimleri Üniversitesi (TR), University of Health Sciences Antigua (AG)
Zero hunger
Openalex Percentile: Top 8%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.